BR0311709A - Processo capaz de hts e sistema de teste para a determinação da interação entre proteìna reativa com relação ao c e componentes que se ligam à proteìna reativa com relação ao c - Google Patents

Processo capaz de hts e sistema de teste para a determinação da interação entre proteìna reativa com relação ao c e componentes que se ligam à proteìna reativa com relação ao c

Info

Publication number
BR0311709A
BR0311709A BR0311709-0A BR0311709A BR0311709A BR 0311709 A BR0311709 A BR 0311709A BR 0311709 A BR0311709 A BR 0311709A BR 0311709 A BR0311709 A BR 0311709A
Authority
BR
Brazil
Prior art keywords
reactive protein
interaction
determining
hts
test system
Prior art date
Application number
BR0311709-0A
Other languages
English (en)
Inventor
Aimo Kannt
Antje Pommereau
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of BR0311709A publication Critical patent/BR0311709A/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4737—C-reactive protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)

Abstract

"PROCESSO CAPAZ DE HTS E SISTEMA DE TESTE PARA A DETERMINAçãO DA INTERAçãO ENTRE PROTEìNA REATIVA COM RELAçãO AO C E COMPONENTES QUE SE LIGAM à PROTEìNA REATIVA COM RELAçãO AO C". A presente invenção refere-se a um processo e sistema de teste capaz de HTS para a determinação da interação entre proteina reativa ao C (CRP) ou C1q e componentes que se ligam ao CRP ou C1 q, para a determinação da concentração de uma solução contendo CRP ou C1q bem como para a determinação de substâncias, que influenciam a interação de CRP ou C1q e componentes que se ligam à mesma, especialmente a interação entre CRP e C1q.
BR0311709-0A 2002-06-12 2003-06-10 Processo capaz de hts e sistema de teste para a determinação da interação entre proteìna reativa com relação ao c e componentes que se ligam à proteìna reativa com relação ao c BR0311709A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10226011A DE10226011A1 (de) 2002-06-12 2002-06-12 HTS-fähiges Verfahren und Testsystem zur Ermittlung der Wechselwirkung zwischen c-reaktivem Protein und an C-reaktives Protein bindenden Komponenten
PCT/EP2003/006038 WO2003107000A2 (de) 2002-06-12 2003-06-10 Hts-fähiges verfahren und testsystem zur ermittlung der wechselwirkung zwischen c-reaktivem protein und an c-reaktives protein bindenden komponenten

Publications (1)

Publication Number Publication Date
BR0311709A true BR0311709A (pt) 2005-03-15

Family

ID=29718976

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0311709-0A BR0311709A (pt) 2002-06-12 2003-06-10 Processo capaz de hts e sistema de teste para a determinação da interação entre proteìna reativa com relação ao c e componentes que se ligam à proteìna reativa com relação ao c

Country Status (14)

Country Link
EP (1) EP1516187A2 (pt)
JP (1) JP2005529348A (pt)
CN (1) CN1745300A (pt)
AR (1) AR040259A1 (pt)
AU (1) AU2003250344A1 (pt)
BR (1) BR0311709A (pt)
CA (1) CA2489021A1 (pt)
DE (1) DE10226011A1 (pt)
MX (1) MXPA04012232A (pt)
NO (1) NO20050037L (pt)
RU (1) RU2005100042A (pt)
TW (1) TW200411179A (pt)
WO (1) WO2003107000A2 (pt)
ZA (1) ZA200409199B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102721813A (zh) * 2012-07-09 2012-10-10 沃克(天津)生物科技有限公司 前列腺特异抗原均相发光免疫分析检测试剂盒及其检测方法
CN103852465A (zh) * 2012-11-30 2014-06-11 通用电气公司 检测标记蛋白的方法和装置
US20180275121A1 (en) * 2015-10-02 2018-09-27 Tgr Biosciences Pty Ltd. Analyte Detection with Multiple Substrates
CN107976535B (zh) * 2017-11-03 2020-03-20 科美诊断技术股份有限公司 一种检测样本中目标IgM抗体的均相免疫检测试剂盒及其使用方法和应用
CN109752332A (zh) * 2017-11-07 2019-05-14 重庆中元汇吉生物技术有限公司 一种补体C1q检测试剂盒
CN108169497A (zh) * 2018-02-11 2018-06-15 北京科美生物技术有限公司 人泌乳素检测试剂盒及其制备方法与应用
CN108445239B (zh) * 2018-02-11 2021-11-02 科美诊断技术股份有限公司 检测β人绒毛膜促性腺激素的均相免疫检测试剂套装及其制备方法和应用
CN108490194A (zh) * 2018-02-11 2018-09-04 北京科美生物技术有限公司 检测卵泡刺激素的均相免疫检测试剂套装及其制备方法和应用
CN108445216B (zh) * 2018-02-11 2021-10-15 科美诊断技术股份有限公司 一种人抗缪勒氏管激素测定试剂盒及其制备方法与应用
CN108445238A (zh) * 2018-02-11 2018-08-24 北京科美生物技术有限公司 检测促黄体生成素的均相免疫检测试剂套装及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU633488B2 (en) * 1988-04-04 1993-02-04 Northwestern University Binding of immune complexes by modified forms of c-reactive protein
US6140490A (en) * 1996-02-01 2000-10-31 Nexstar Pharmaceuticals, Inc. High affinity nucleic acid ligands of complement system proteins
US5283238A (en) * 1992-04-24 1994-02-01 Immtech International, Inc. Methods of treating cancer using modified C-reactive protein
DE69417242T2 (de) * 1993-09-03 1999-07-08 Behringwerke Ag Fluoreszenz-sauerstoffkanalisation-immunteste
US6303325B1 (en) * 1998-05-29 2001-10-16 Dade Behring Inc. Method for detecting analytes

Also Published As

Publication number Publication date
AU2003250344A1 (en) 2003-12-31
NO20050037L (no) 2005-01-04
CN1745300A (zh) 2006-03-08
RU2005100042A (ru) 2006-07-20
ZA200409199B (en) 2005-05-18
WO2003107000A2 (de) 2003-12-24
JP2005529348A (ja) 2005-09-29
AR040259A1 (es) 2005-03-23
DE10226011A1 (de) 2004-01-08
CA2489021A1 (en) 2003-12-24
WO2003107000A3 (de) 2004-05-27
TW200411179A (en) 2004-07-01
MXPA04012232A (es) 2005-02-25
EP1516187A2 (de) 2005-03-23

Similar Documents

Publication Publication Date Title
ATE541054T1 (de) Bio-barcode erkennung für zielmoleküle
AR027346A1 (es) Tira de analisis reactiva para la determinacion de analitos
CY1107490T1 (el) Μεθοδος για την ταυτοποιηση δειγματος σε θηλαστικα καθως και κιτ για την εκτελεση αυτης της μεθοδου
ATE431853T1 (de) Auf oligonukleotid-modifizierten partikeln basierende bio-strichcodes
ATE476494T1 (de) Lichtdurchlässige festmatrix-prüfvorrichtung zur mikroarray-analyse
ATE428931T1 (de) Verfahren zur durchführung von vollbluttests
DE602004017201D1 (de) Nachweis einer histonmodifikation in zellfreien nukleosomen
MX2009004460A (es) Inmunoensayo de analitos en muestras que contienen anticuerpos anti-analito endogenos.
BRPI0603523A (pt) teste de solução de reprocessador de endoscópio automatizado
ATE431854T1 (de) Auf bio-barcodes beruhender nachweis von zielanalyten
DE69833378D1 (de) Fluoreszierende polarisation
BRPI0505096A (pt) processo de separação por eletroforese capilar das hemoglobinas em amostras biológicas, utilização de um redutor de fluxo escolhido dentre as diaminas e poliaminas alifáticas e cìclicas, e, kit de análise da hemoglobina por eletroforese capilar
Jakó et al. Chiral analysis of amino acid neurotransmitters and neuromodulators in mouse brain by CE‐LIF
BR9812876A (pt) Dispositivo de ensaio que permite detectar a presença de analitos em um laticìnio lìquido, processos para a detecção de analitos em um laticìnio lìquido e para a preparação de um dispositivo de ensaio, e, estojo de ensaio
BR0311709A (pt) Processo capaz de hts e sistema de teste para a determinação da interação entre proteìna reativa com relação ao c e componentes que se ligam à proteìna reativa com relação ao c
ATE405832T1 (de) Verfahren zur erhöhung des dynamischen messbereichs von auf spezifischen bindereaktionen basierenden, insbesondere immunologischen testelementen
CY1113490T1 (el) Μεθοδος διαχωρισμου πρωτεϊνων με τριχοειδη ηλεκτροφορηση και συνθεσεις ρυθμιστικου για τριχοειδη ηλεκτροφορηση
BR112019000742A2 (pt) método e kit para analisar uma amostra
Keyon et al. Transient isotachophoresis-capillary zone electrophoresis with contactless conductivity and ultraviolet detection for the analysis of paralytic shellfish toxins in mussel samples
Nielsen et al. Microchip electrophoresis separation of a panel of preterm birth biomarkers
ATE473290T1 (de) Proteomweite quantifizierung kleiner an zelluläre zielproteine gebundener moleküle
DE602005013430D1 (de) Verwendung von asc als marker für kolorektalkarzinome
ATE547161T1 (de) Verfahren zur quantitativen bestimmung von poloxameren
BRPI0416270A (pt) método para detectar um analito em uma amostra, e, método e kit para detectar um anticorpo especìfico de uma amostra
BRPI0404322A (pt) Controle a bordo para elementos analìticos

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: SANOFI-AVENTIS DEUTSCHLAND GMBH (DE)

Free format text: ALTERADO DE: AVENTIS PHARMA DEUTSCHLAND GMBH

B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 5A,6A E 7A ANUIDADES

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2064 DE 27/07/2010.